A case is presented of a 30-year-old female with treatment-resistant schizoaffective disorder who was referred to a tertiary-level specialist psychosis service. We describe the history of clozapine trials and associated episodes of agranulocytosis and neutropenia, followed by the successfully tolerated third clozapine re-challenge within our service.</p
Clozapine is the only drug with confirmed efficacy for refractory schizophrenia; however, its use is...
Clozapine has been widely used as an antipsychotic drug for the treatment of refractory schizophreni...
In a 37-year-old female, a combined treatment consisting of chemotherapy and radiation was considere...
A case is presented of a 30-year-old female with treatment-resistant schizoaffective disorder who wa...
Clozapine is a second-generation antipsychotic agent from the benzodiazepine group indicated for tre...
Objective: Clozapine remains the most effective intervention for treatment resistant schizophrenia; ...
This case outlines recurrent neutropenia after fourteen years of successful clozapine use. The patie...
Clozapine is thefirst antipsychotic drug with proven superiority overconventional antipsychot-ics in...
In a 37-year-old female, a combined treatment consisting of chemotherapy and radiation was considere...
Clozapine is the first antipsychotic drug with proven superiority over conventional antipsychotics i...
The clinical management of patients with treatment-resistant psychotic disorders is still challengin...
Clozapine is an atypical antipsychotic drug that is approved by the US Food and Drug Administration ...
Clozapine, the choice atypical antipsychotic for refractory schizophrenia, schizoaffective disorder,...
Wider use of clozapine, one of the most effective antipshychotic drugs, is precluded by its propensi...
Tariq Munshi, Mir Mazhar, Tariq HassanDepartment of Psychiatry, Kingston General Hospital, Kingston,...
Clozapine is the only drug with confirmed efficacy for refractory schizophrenia; however, its use is...
Clozapine has been widely used as an antipsychotic drug for the treatment of refractory schizophreni...
In a 37-year-old female, a combined treatment consisting of chemotherapy and radiation was considere...
A case is presented of a 30-year-old female with treatment-resistant schizoaffective disorder who wa...
Clozapine is a second-generation antipsychotic agent from the benzodiazepine group indicated for tre...
Objective: Clozapine remains the most effective intervention for treatment resistant schizophrenia; ...
This case outlines recurrent neutropenia after fourteen years of successful clozapine use. The patie...
Clozapine is thefirst antipsychotic drug with proven superiority overconventional antipsychot-ics in...
In a 37-year-old female, a combined treatment consisting of chemotherapy and radiation was considere...
Clozapine is the first antipsychotic drug with proven superiority over conventional antipsychotics i...
The clinical management of patients with treatment-resistant psychotic disorders is still challengin...
Clozapine is an atypical antipsychotic drug that is approved by the US Food and Drug Administration ...
Clozapine, the choice atypical antipsychotic for refractory schizophrenia, schizoaffective disorder,...
Wider use of clozapine, one of the most effective antipshychotic drugs, is precluded by its propensi...
Tariq Munshi, Mir Mazhar, Tariq HassanDepartment of Psychiatry, Kingston General Hospital, Kingston,...
Clozapine is the only drug with confirmed efficacy for refractory schizophrenia; however, its use is...
Clozapine has been widely used as an antipsychotic drug for the treatment of refractory schizophreni...
In a 37-year-old female, a combined treatment consisting of chemotherapy and radiation was considere...